Cargando…
Preliminary investigation of drug impurities associated with the anti-influenza drug Favipiravir – An insilico approach
The role of repurposed or modified antiviral drugs has become more significant during the current global pandemic of SARS Covid-19. In the present study, four structurally analogous impurity molecules of antiviral drug Favipiravir are selected for preliminary computational investigation for assessin...
Autores principales: | Anil Kumar, S., Bhaskar, B.L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285362/ https://www.ncbi.nlm.nih.gov/pubmed/34306990 http://dx.doi.org/10.1016/j.comptc.2021.113375 |
Ejemplares similares
-
Prediction of anti-inflammatory proteins/peptides: an insilico approach
por: Gupta, Sudheer, et al.
Publicado: (2017) -
Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
por: Shiraki, Kimiyasu, et al.
Publicado: (2020) -
PHARMIP: An insilico method to predict genetics that underpin adverse drug reactions
por: Zidan, Ahmad M., et al.
Publicado: (2019) -
Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2
por: Peele, K.Abraham, et al.
Publicado: (2021) -
Interaction between favipiravir and hydroxychloroquine and their combined drug assessment: in silico investigations
por: Parlak, Cemal, et al.
Publicado: (2021)